date:Jul 09, 2014
two partners to a key position for fully integrated drug development. This is seen internationally as being very unique, said Dr. Holger Zinke, CEO of BRAIN, of the importance of the newly formed partnership. The alliance combines the development of novel screening tests with direct access to an infinite source of natural products, therefore offering the opportunity to additionally optimise certain natural product candidates through chemical synthesis, in terms of properties such as stability, s